{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:34:16Z","timestamp":1769038456169,"version":"3.49.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.iac.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T19:25:40Z","timestamp":1473881140000},"page":"719-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"John W.","family":"Steinke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer C.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2016.06.008_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2016.06.008_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/alr.20003","article-title":"Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007","volume":"1","author":"Mattos","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2016.06.008_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0091-6749(99)70106-5","article-title":"Aspirin-induced asthma: advances in pathogenesis and management","volume":"104","author":"Szczeklik","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib5","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1136\/thorax.55.suppl_2.S42","article-title":"Clinical features and diagnosis of aspirin induced asthma","volume":"55","author":"Szczeklik","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2016.06.008_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2016.06.008_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","article-title":"Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease","volume":"94","author":"Mascia","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0091-6749(94)90123-6","article-title":"Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma","volume":"94","author":"Fischer","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A\u00a0controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.2101021","article-title":"Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma","volume":"166","author":"Antczak","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","article-title":"Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics","volume":"160","author":"Picado","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2005.10.037","article-title":"Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells","volume":"117","author":"Ying","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mai.2003.67","article-title":"Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma","volume":"111","author":"Steinke","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib19","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0400235101","article-title":"Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis","volume":"101","author":"Beller","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2016.06.008_bib20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1189\/jlb.0812374","article-title":"Editorial: Yin-Yang of EP receptor expression","volume":"92","author":"Steinke","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.1979","article-title":"Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma","volume":"209","author":"Adamjee","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.iac.2016.06.008_bib22","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.iac.2016.06.008_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iac.2016.06.008_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1081-1206(10)62815-3","article-title":"Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients","volume":"81","author":"Park","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaci.2012.02.007","article-title":"Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma","volume":"129","author":"Corrigan","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.182.1.49","article-title":"Differentiation in\u00a0vitro of hybrid eosinophil\/basophile granulocytes: autocrine function of an eosinophil intermediate","volume":"182","author":"Boyce","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib27","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1067\/mai.2000.110156","article-title":"Systemic aspects of allergic disease: bone marrow responses","volume":"106","author":"Denburg","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1165\/ajrcmb.20.3.3060","article-title":"Immunolocalization of CD34 in nasal polyp. Effect of topical corticosteroids","volume":"20","author":"Kim","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib29","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1101\/gad.12.15.2403","article-title":"PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors","volume":"12","author":"Nerlov","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.iac.2016.06.008_bib30","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1101\/gad.12.15.2413","article-title":"Distinct C\/EBP functions are required for eosinophil lineage commitment and maturation","volume":"12","author":"Nerlov","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.iac.2016.06.008_bib31","doi-asserted-by":"crossref","first-page":"F43","DOI":"10.1084\/jem.20020636","article-title":"Making eosinophils through subtle shifts in transcription factor expression","volume":"195","author":"McNagny","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.20020170","article-title":"Essential and instructive roles of GATA factors in eosinophil development","volume":"195","author":"Hirasawa","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1091\/mbc.6.5.497","article-title":"A\u00a0human-GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF","volume":"6","author":"Nishijima","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib34","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.008_bib35","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in\u00a0vivo","volume":"182","author":"Collins","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib36","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.4049\/jimmunol.181.7.5045","article-title":"IFN consensus sequence binding protein (ICSBP) is critical for eosinophil development","volume":"181","author":"Milanovic","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of interferon-\u03b3 in aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib38","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2009-12-261339","article-title":"Eosinophil differentiation in the bone marrow is inhibited by T\u00a0cell-derived IFN-gamma","volume":"116","author":"de Bruin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.008_bib39","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.008_bib40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells","volume":"148","author":"Kirshenbaum","year":"1992","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(90)90304-W","article-title":"Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms","volume":"63","author":"Anderson","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.iac.2016.06.008_bib42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.008_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2016.06.008_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaip.2014.05.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease.","volume":"2","author":"Payne","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2016.06.008_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000237600","article-title":"Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients","volume":"113","author":"Sampson","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.008_bib47","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2007-07-100453","article-title":"CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells","volume":"110","author":"Jiang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.008_bib48","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2016.06.008_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.iac.2016.06.008_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/ajrccm\/144.4.957","article-title":"The potent and selective sulfidopeptide leukotriene antagonists, SK&F 104353, inhibits aspirin-induced asthma","volume":"144","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.008_bib51","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-27","article-title":"Treatment of aspirin-intolerant asthma with antileukotrienes","volume":"161","author":"Dahlen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.bjp.0704991","article-title":"Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle","volume":"137","author":"Walch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.iac.2016.06.008_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","article-title":"Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib54","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/ajrccm\/146.6.1506","article-title":"Effect of indomethacin on leukotriene4-induced histamine hyperresponsiveness in asthmatic subjects","volume":"146","author":"Christie","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.008_bib55","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1183\/09031936.93.06101468","article-title":"Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects","volume":"6","author":"Christie","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.06.008_bib56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene E4 and granulocytic infiltration into asthmatic airways","volume":"341","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2016.06.008_bib57","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/ajrccm.164.8.2102033","article-title":"Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma","volume":"164","author":"Gauvreau","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib58","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","article-title":"Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors","volume":"105","author":"Maekawa","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2016.06.008_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2005.09.052","article-title":"Identification of endogenous surrogate ligands for human P2Y12 receptors by in\u00a0silico and in\u00a0vitro methods","volume":"337","author":"Nonaka","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.iac.2016.06.008_bib60","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib61","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2016.06.008_bib62","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib64","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1101806","article-title":"Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation","volume":"187","author":"Luna-Gomes","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.042","article-title":"Eosinophil production of PGD2 in aspirin-exacerbated respiratory disease.","author":"Feng","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib67","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.177.4.2621","article-title":"Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor","volume":"177","author":"Satoh","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib68","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.179.7.4792","article-title":"The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking","volume":"179","author":"Schratl","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2014.08.027","article-title":"D\u00a0prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells","volume":"135","author":"Stinson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2222.2006.02528.x","article-title":"Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis","volume":"36","author":"Okano","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.008_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archotol.133.7.693","article-title":"Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps","volume":"133","author":"Hyo","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.iac.2016.06.008_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00016489950181819","article-title":"Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics","volume":"119","author":"Schmid","year":"1999","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.iac.2016.06.008_bib73","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PgE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib74","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2005-07-2772","article-title":"Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses","volume":"107","author":"Feng","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2016.06.008_bib75","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1189\/jlb.0212109","article-title":"E-prostanoid 2 receptors dampen mast cell degranulation via cAMP\/PKA-mediated suppression of IgE-dependent signaling","volume":"92","author":"Serra-Pages","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib76","doi-asserted-by":"crossref","first-page":"37937","DOI":"10.1074\/jbc.M305108200","article-title":"Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2","volume":"278","author":"Murakami","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2016.06.008_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/194589240501900201","article-title":"New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis","volume":"19","author":"Gosepath","year":"2005","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.iac.2016.06.008_bib78","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2009.07.031","article-title":"Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization","volume":"124","author":"Steinke","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib79","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib80","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1027\/0838-1925.11.4.130","article-title":"Nasal polyposis - A new concept on the formation of polyps","volume":"11","author":"Bachert","year":"1999","journal-title":"Allergy Clin Immunol Int"},{"key":"10.1016\/j.iac.2016.06.008_bib82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/ajrcmb.17.6.2865","article-title":"Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis","volume":"17","author":"Minshall","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib83","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2222.1998.00380.x","article-title":"IL-5, and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis","volume":"28","author":"Hamilos","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.008_bib84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0194-5998(98)70273-6","article-title":"Comparison of inflammatory cell profile and Th2 cytokine expression in the ethmoid sinuses, maxillary sinuses, and turbinates of atopic subjects with chronic sinusitis","volume":"18","author":"Kamil","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.iac.2016.06.008_bib85","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2222.2005.02316.x","article-title":"Nasal biomarker profiles in acute and chronic rhinosinusitis","volume":"35","author":"Riechelmann","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.008_bib86","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib87","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.008_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib89","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","article-title":"Differentiation of chronic sinus diseases by measurement of inflammatory mediators","volume":"61","author":"Van Zele","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.008_bib90","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2500\/aap.2007.28.3052","article-title":"Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"28","author":"Shome","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2016.06.008_bib91","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaci.2009.04.031","article-title":"Eosinophil-derived IFN-\u03b3 induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes","volume":"124","author":"Kanda","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib92","first-page":"113","article-title":"Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity?","volume":"3","author":"Akuthota","year":"2011","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.iac.2016.06.008_bib93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.0108058","article-title":"Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially","volume":"85","author":"Spencer","year":"2009","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.193.1.123","article-title":"T\u00a0helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4","volume":"193","author":"Hsieh","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib95","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.008_bib96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20020044","article-title":"Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists","volume":"195","author":"Mellor","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.008_bib97","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.2034927100","article-title":"Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R","volume":"100","author":"Mellor","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2016.06.008_bib98","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.167.5.2855","article-title":"IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages","volume":"167","author":"Thivierge","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2006-0252OC","article-title":"Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-g on peripheral immune cells","volume":"36","author":"Early","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2016.06.008_bib100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jcp.1041650110","article-title":"Interleukin-4 inhibits lipopolysaccharide-induced expression of prostaglandin H synthase-2 in human alveolar macrophages","volume":"165","author":"Yano","year":"1995","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.iac.2016.06.008_bib101","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0090-6980(97)89598-6","article-title":"Differential sensitivities of human blood monocytes and alveolar macrophages to the inhibition of prostaglandin endoperoxide synthase-2 by interleukin-4","volume":"53","author":"Dworski","year":"1997","journal-title":"Prostaglandins"},{"key":"10.1016\/j.iac.2016.06.008_bib102","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbrc.2006.03.073","article-title":"IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer","volume":"343","author":"Cui","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.iac.2016.06.008_bib103","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jaci.2006.01.049","article-title":"Selective downregulation of prostaglandin E2-related pathways by the TH2 cytokine IL-13","volume":"117","author":"Trudeau","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib104","doi-asserted-by":"crossref","first-page":"29138","DOI":"10.1074\/jbc.274.41.29138","article-title":"Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases","volume":"274","author":"Matsuura","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2016.06.008_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.molimm.2015.03.003","article-title":"Interferon-gamma stimulates human follicular dendritic cell-like cells to produce prostaglandins via the JAK-STAT pathway","volume":"66","author":"Kim","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib106","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0897.2004.00162.x","article-title":"IFN-gamma-mediated inhibition of COX-2 expression in the placenta from term and preterm labor pregnancies","volume":"51","author":"Hanna","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.iac.2016.06.008_bib107","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/sj.onc.1210015","article-title":"STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation","volume":"26","author":"Klampfer","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.iac.2016.06.008_bib108","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2016.06.008_bib109","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1136\/thorax.55.suppl_2.S24","article-title":"Haemopoietic mechanisms in nasal polyposis and asthma","volume":"55","author":"Denburg","year":"2000","journal-title":"Thorax"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:33:43Z","timestamp":1692502423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0889856116300534"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.008","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}